Collection of Blood Specimens for Circulating Tumor Cell Analysis

Completed

Conditions studied: Breast Cancer, Prostate Cancer, Colorectal Cancer

In brief

Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).

Key facts

Study ID

NCT01943500

Run by

Viatar LLC

People needed

14

Starts

2013-09-30

Expected to finish

2016-08-26

Last updated by the study team

2017-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age > 18 years of age
• Written informed consent obtained
• Confirmed diagnosis of stage 2-4 breast, prostate, or colorectal cancer, (OR) no prior history of cancer
• Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients
• Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject

You may not qualify if…

• Patients unable to understand the research protocol and/or provide informed consent.
• Patients with known immunodeficiency, or pregnancy.

Where it is running

• Commonwealth Hematology-Oncology, P.C. — Lawrence, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.